Viramed® Biotech AG

Viramed® Biotech AG

Based on more than 40 years of experience in European and American markets Viramed® develops, produces and sells In-Vitro-Diagnostic test kits. Through research and development, the ViraChip^® microarray product group is continuously expanding.

Viramed^® focuses on the serological detection of autoantibodies and antibodies against infectious disease parameters like Borrelia, Yersinia, Treponema+VDRL, Helicobacter, Bordetella, SARS-CoV-2, EBV, CMV, Hepatitis E Virus, Parvovirus B19, Zika Virus, Dengue Virus, Chikungunya Virus and Toxoplasma.

Software solutions, device design and manufacturing provide full automation for the ViraChip^® technology in the diagnostic laboratory.